Close this search box.

Is Innovation the Answer to America’s Opioid Epidemic?

The Food and Drug Administration has approved two generic versions of an innovative drug to treat opioid addiction, increasing available treatment options for Americans fighting addiction.  The move underscores a growing realization among policymakers, regulators and industry: to address the opioid crisis, innovative solutions must be readily available.

Balancing Opioid Policy and Pain Management

Thursday marked the White House Opioid Summit, which welcomed 200 affected Americans to discuss the crisis with Cabinet members.  President Donald Trump declared the opioid abuse epidemic a public health emergency last fall.